AMPH Amphastar Pharmaceuticals, Inc.

8-K Current Report

Filed: February 26, 2026

Health Care

Pharmaceutical Preparations

Amphastar Pharmaceuticals, Inc. Overview

Amphastar Pharmaceuticals, Inc. (AMPH) 8-K current report filed with SEC EDGAR on February 26, 2026. This page provides AI-powered analysis of reported events and material disclosures, including results of operations, corporate governance changes, agreements, and other triggering events as disclosed under Form 8-K item codes.

Reported 8-K Items
1 item

Item 2.02: Results of Operations and Financial Condition

AI Filing Analysis
8-K

Item 2.02 · Results of Operations and Financial Condition

• Q4 and full-year fiscal 2025 earnings results announced Feb 26, 2026
• Full financials in Exhibit 99.1 press release — primary source for revenue, EPS, and guidance details

Other Amphastar Pharmaceuticals, Inc. 8-K Filings

8-K Mar 16, 2026

8-K Mar 6, 2026

Get deeper insights on Amphastar Pharmaceuticals, Inc.

Access full AI analysis, insider trading data, fund holdings, and cross-signal detection on SignalX.